Evidence based medicine (EBM) and diagnostics (EBD) are key techniques for HTA evaluations.
We cooperate actively with social security institutions in the newest developments in these research areas.
From our perspective many HTA projects lack sufficient consideration of diagnosis validity and appropriate meta-
The impact of a possible, future target "minimisation time to a validated diagnosis in medical practice" could have huge economical and patient satisfaction benefits.
Our perspective strongly indicates that current evidence based diagnostics lacks ONE strategic HTA element: Demand for therapeutic interventions vs a doctor's advice for some time of rest.
Our wealth of experiences in the pharmaceutical sector in the areas of clinical trials and of meta-